- The Indian stock market indices ended at record highs as foreign investors continued to purchase equities, supported by economic reforms and lower global oil prices. - However, India's services PMI fell to its lowest level in six months, indicating a slowdown in growth of the services sector. - Selected company news is provided, including losses for Wockhardt and gains for Ranbaxy which received FDA approval for a new drug.

1. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.
DAILY EQUITY REPORT 7th November 2014

2. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.
Daily Equity Report INDIAN MARKET
INDIAN FACE
 INDIAN EQUITY BENCHMARK ended at record closing highs and the Sensex topped 28,000 mark intra-days for the first time as foreign institutional investors remained aggressive buyers in equities. Slew of economic reforms recently announced by the government along with decline in global crude oil prices aided the buying interest of the investors.
 Further, The HSBC Purchasing Managers' Index (PMI), compiled by Market, fell to 50 in October from September's 51.6, the lowest in six months and right on the break-even point between growth and contraction.
 Wockhardt lost 2.36% after consolidated net profit fell 98% to Rs3 crore on 14% decline in sales to Rs1029 crore in Q2 September 2014 over Q2 September 2013.
GLOBAL FACE
 Asian shares got off to a lackluster start after a plunge in oil prices dragged down U.S. shares, while the dollar took a breather after this week's rally.
 European shares rose early on Wednesday, reversing most of the previous session's losses, as a raft of positive results from companies helped lift sentiment.
 US stock index futures poised for a higher opening at the Wall Street on Wednesday.
INDICES
CLOSE
PREVIOUS
SENSEX
27,915.88
27,860.38
NIFTY
8,338.30
8,324.15 ASIAN MARKET
INDICES
CLOSE
PREVIOUS
NIKKEI
16,937.32
16,862.47
HANG SENG
23,695.62
23,845.66
KOSPI
1,931.43
1,935.19 SECTORIAL INDICES
INDICES
CLOSE
CHANGE (%)
CNX 100
8,276.00
0.12
S&P CNX 500
6,716.25
0.18
CNX MIDCAP
11,975.60
0.14
CNX 200
4,251.55
0.15
BANK NIFTY
17,371.60
1.39 TOP GAINERS
SCRIPT
CLOSE
CHANGE (%)
AXIS BANK
460.55
3.44
HCL TECH
1,608.75
2.42
DR REDDY
3,258.00
2.41
BPCL
741.10
2.35 TOP LOSERS
SCRIPT
CLOSE
CHANGE (%)
JINDALSTEL
161.35
-5.17
CAIRN
276.70
-4.85
HINDALCO
156.20
-4.49
SSLT
251.75
-4.00

3. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.
Daily Equity Report MARKET MOVERS UPSIDE
NIFTY SPOT TREND STRATEGY
BULLISH
BUY ON DIPS PIVOT POINTS
S3
S2
S1
P
R1
R2
R3
8258
8300
8319
8342
8361
8384
8426 NIFTY SUPPORT RESISTANCE
S1-8320
R1-8370
S2-8290
R2-8430 BANK NIFTY FUTURE TREND STRATEGY
BULLISH
BUY ON DIPS PIVOT POINTS
S3
S2
S1
P
R1
R2
R3
16760
17086
17279
17412
17605
17737
18063 BANK NIFTY SUPPORT RESISTANCE
S1-17300
R1-17550
S2-17150
R2-17750
SCRIPT
CLOSE
CHANGE (%)
TCS
2599.50
0.35
ITC
359.15
1.04
INFOSYS
4124.80
0.95
HDFC BANK
912.80
0.23 MARKET MOVERS DOWNSIDE
SCRIPT
CLOSE
CHANGE (%)
ONGC
403.60
[0.23]
RELIANCE
991.30
[1.1]
COAL INDIA
349.10
[2.81]
HDFC
1100.55
[1.78] FII & DII ACTIVITY
INSTITUTION
NET BUY (CR.)
NET SELL (CR)
FII
4459.07
3045.73
DII
1334.20
2517.28 NSE TOTALS
INDICES
ADVANCES
DECLINES
NIFTY
23
27
BANK NIFTY
8
4

4. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.
Daily Equity Report r MARKET TALKS
Mumbai based Loop Mobile, for about Rs 700 crore, Report stated that the approval for the transaction was awaited from the relevant authorities as a result of which Bharti Airtel has withdrawn from the proposed transaction causing huge loss to the company.
 Ranbaxy gets USFDA nod for Fenofibrate Capsules...stock up 3%
Ranbaxy has received approval from the U.S. FDA to manufacture and market Fenofibrate Capsules USP, 43 mg and 130 mg. The Office of Generic Drugs, U.S. FDA, has determined the Ranbaxy formulations to be bioequivalent and have the same therapeutic effect as that of the reference listed drug Antara(R) Capsules, 43 and 130 mg, respectively, of Lupin Atlantis (Lupin).
 GlaxoSmithKline Consumer Q2 net profit at Rs1602.90 mn
GlaxoSmithKline Consumer Healthcare Ltd has posted a net profit of Rs. 1602.90 mn for the quarter ended Sept 30, 2014 whereas the same was at net profit of Rs. 1469.30 mn for the quarter ended Sep 30, 2013.Total Income is Rs. 11754.60 mn for the quarter ended Sep 30, 2014 whereas the same was at Rs. 10574.70 million for the quarter ended Sep 30, 2013..
 India HSBC Oct Services PMI at 6- month
The HSBC Purchasing Managers' Index fell to 50 in October from September's 51.6, the lowest in six months and right on the break- even point between growth and contraction. New business growth slowed a five-month low but continued to expand at a modest pace. Growth in India's dominant service industry stalled last month as new orders came in at a weaker pace,
 Hexaware Technologies Q3 cons net profit at Rs86 crores
Hexaware Technologies Ltd has posted a net profit of Rs. 860.202 Mn for the quarter ended September 30, 2014 whereas the same was at Rs. 987.236 mn for the quarter ended September 30, 2013. Total Income is Rs. 6737.170 million for the quarter ended September 30, 2014 whereas the same was at Rs. 6278.286 million for the quarter ended September 30, 2013.
 Bharti Airtel calls off deal to buy Loop
Bharti Airtel has called off deal to acquire business and assets of
The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most. Use of this report in no way constitutes a client/advisor relationship, all information we communicate to you (the subscriber) either through our Web site or other forms of communications, are purely for informational purposes only. We recommend seeking individual investment advice before making any investment, for you are assuming sole liability for your investments. Capital Stars will in no way have discretionary authority over your trading or investment accounts. All rights reserved.
DISCLAIMER